1. “Current Concepts in the Diagnosis and Management of Cytokine Release Syndrome,”;Lee;Blood,2014
2. 27. 21 U.S.C. § 360ff (2016).
3. 17. Grady, D. , "F.D.A. Panel Recommends Approval for Gene-Altering Leukemia Treatment," New York Times, July 12, 2017, available at (last visited Nov. 30, 2017)
4. Mukherjee, S. , "FDA Panel Backs Groundbreaking Novartis Treatment That Turns Your Cells Into Cancer Killers," Fortune, July 12, 2017, available at < http://fortune.com/2017/07/12/fda-novartis-car-t-cancer-treatment/> (last visited Nov. 30, 2017).
5. 12. See O’Leary, supra note 10, at 24.